Maybe the reason they collaborated with AMBS was cause they weren't getting very far on their own with that grant money. PLus AMBS had the patent for MANF, which we have learned, covers 90% of the variances. When it comes to TBI, Banyan doesn't have much else goin for them from what I read. I wouldn't be surprised to hear their bname mentioned again down the road